Kamada Ltd. (KMDA)

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attract...

The consensus price target hints at a 106.9% upside potential for Kamada (KMDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or CSL Limited Sponsored ADR (CSLLY). But which of these two stocks presents in...

The mean of analysts' price targets for Kamada (KMDA) points to a 106.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

Start Time: 08:30 January 1, 0000 8:53 AM ET Kamada Ltd. (NASDAQ:KMDA ) Q1 2025 Earnings Conference Call May 14, 2025, 08:30 AM ET Company Participants Amir London - CEO Chaime Orlev - CFO Brian Ritch...

While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to...

Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.

Besides Wall Street's top -and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua...